Gabelli & Co Investment Advisers’s Urovant Sciences Ltd. UROV Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-159,135	Closed	-$2.57M	–	513
2020 Q4	$2.57M	Buy	+159,135	New	+$1.97M	0.4%	51

Gabelli & Co Investment Advisers's UROV Position: Q1 2021 in Review

Gabelli & Co Investment Advisers sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 159,135 shares — an estimated $2.57M sold.

Gabelli & Co Investment Advisers first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $2.57M in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Gabelli & Co Investment Advisers reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 159,135 Urovant Sciences Ltd. shares in Q1 2021, an estimated $2.57M.
Gabelli & Co Investment Advisers first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Urovant Sciences Ltd. position peaked at $2.57M in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2021, filed 14 May 2021.